Action Mechanism

Understanding how hormones work at the cellular level is key to understanding endocrinology. Hormones initiate their effects by binding to receptors, triggering a cascade of intracellular events

Hormone Receptors

  • Definition: Proteins located either on the cell surface or within the cell that bind to specific hormones, initiating a cellular response
  • Types of Receptors
    • Cell Surface Receptors: Typically bind to peptide hormones and catecholamines
      • G Protein-Coupled Receptors (GPCRs): Activate intracellular signaling pathways through G proteins
      • Receptor Tyrosine Kinases (RTKs): Initiate phosphorylation cascades, leading to altered gene expression and cellular function
      • Cytokine Receptors: Activate intracellular signaling pathways through Janus kinases (JAKs) and signal transducers and activators of transcription (STATs)
    • Intracellular Receptors: Located in the cytoplasm or nucleus, typically bind to steroid hormones and thyroid hormones
      • Nuclear Receptors: Regulate gene transcription by binding to DNA response elements

Mechanisms of Hormone Action

  • Peptide Hormones and Catecholamines
    • Binding to Cell Surface Receptors:
      • Hormone binds to a specific receptor on the cell membrane
      • Receptor undergoes a conformational change, activating intracellular signaling pathways
    • Activation of G Proteins:
      • GPCRs activate G proteins (Gs, Gi, Gq)
      • Gs stimulates adenylyl cyclase, increasing cAMP levels
      • Gi inhibits adenylyl cyclase, decreasing cAMP levels
      • Gq activates phospholipase C, increasing IP3 and DAG levels
    • Activation of Second Messengers:
      • cAMP activates protein kinase A (PKA), which phosphorylates target proteins, altering their activity
      • IP3 releases calcium from the endoplasmic reticulum, activating protein kinase C (PKC) and other calcium-dependent signaling pathways
      • DAG activates PKC, which phosphorylates target proteins
    • Activation of Receptor Tyrosine Kinases (RTKs):
      • Hormone binding causes receptor dimerization and autophosphorylation
      • Phosphorylated tyrosine residues recruit intracellular signaling proteins, such as SH2 domain-containing proteins
      • Activation of downstream signaling pathways, including the MAPK/ERK pathway and the PI3K/Akt pathway
    • Signal Amplification:
      • The initial hormone-receptor interaction is amplified through signaling cascades, leading to a large cellular response
    • Cellular Response:
      • Changes in enzyme activity, gene expression, and cellular function
  • Steroid Hormones and Thyroid Hormones
    • Entry into the Cell:
      • Hormone diffuses across the cell membrane and enters the cytoplasm
    • Binding to Intracellular Receptors:
      • Hormone binds to a specific receptor in the cytoplasm or nucleus
      • Receptor undergoes a conformational change, forming a hormone-receptor complex
    • Translocation to the Nucleus (if receptor is cytoplasmic):
      • Hormone-receptor complex translocates to the nucleus
    • Binding to DNA:
      • Hormone-receptor complex binds to specific DNA response elements (HREs) in the promoter region of target genes
    • Regulation of Gene Transcription:
      • The hormone-receptor complex recruits coactivator or corepressor proteins, altering gene transcription
      • Increased transcription leads to increased mRNA synthesis and protein production
      • Decreased transcription leads to decreased mRNA synthesis and protein production
    • Cellular Response:
      • Changes in protein synthesis and cellular function

Detailed Mechanisms

  • G Protein-Coupled Receptors (GPCRs)
    • Structure:
      • GPCRs are transmembrane proteins with seven transmembrane domains
      • The extracellular domain binds to the hormone, while the intracellular domain interacts with G proteins
    • Activation:
      • Hormone binding causes a conformational change in the receptor, activating the associated G protein
      • G proteins consist of three subunits: alpha, beta, and gamma
      • The alpha subunit binds to GTP and has intrinsic GTPase activity
      • Activation of the G protein causes the alpha subunit to dissociate and activate or inhibit downstream effectors
    • Downstream Effectors:
      • Adenylyl cyclase: Stimulated by Gs, inhibited by Gi
        • Adenylyl cyclase catalyzes the conversion of ATP to cAMP
        • cAMP activates protein kinase A (PKA)
      • Phospholipase C: Activated by Gq
        • Phospholipase C catalyzes the hydrolysis of PIP2 to IP3 and DAG
        • IP3 releases calcium from the endoplasmic reticulum
        • DAG activates protein kinase C (PKC)
    • Termination of Signal:
      • The intrinsic GTPase activity of the G protein alpha subunit hydrolyzes GTP to GDP, inactivating the G protein
      • Phosphodiesterases degrade cAMP, reducing PKA activity
      • Calcium pumps remove calcium from the cytoplasm, reducing PKC activity
  • Receptor Tyrosine Kinases (RTKs)
    • Structure:
      • RTKs are transmembrane proteins with an extracellular domain that binds to the hormone and an intracellular domain with tyrosine kinase activity
    • Activation:
      • Hormone binding causes receptor dimerization and autophosphorylation of tyrosine residues in the intracellular domain
      • Phosphorylated tyrosine residues serve as docking sites for intracellular signaling proteins with SH2 domains
    • Downstream Signaling Pathways:
      • MAPK/ERK Pathway:
        • Activated by growth factors, such as epidermal growth factor (EGF)
        • Involves a cascade of protein kinases: Ras -> Raf -> MEK -> ERK
        • ERK phosphorylates transcription factors, altering gene expression
      • PI3K/Akt Pathway:
        • Activated by insulin and growth factors
        • Involves phosphatidylinositol 3-kinase (PI3K) and Akt
        • Akt promotes cell survival, growth, and metabolism
    • Termination of Signal:
      • Protein phosphatases remove phosphate groups from tyrosine residues, inactivating the receptor
      • GTPase-activating proteins (GAPs) inactivate Ras by promoting GTP hydrolysis
  • Nuclear Receptors
    • Structure:
      • Nuclear receptors are intracellular proteins with a DNA-binding domain and a ligand-binding domain
      • The DNA-binding domain contains zinc finger motifs that recognize specific DNA sequences (response elements)
    • Activation:
      • Hormone enters the cell and binds to the receptor, causing a conformational change
      • The hormone-receptor complex translocates to the nucleus (if the receptor is cytoplasmic)
    • Regulation of Gene Transcription:
      • The hormone-receptor complex binds to specific DNA response elements (HREs) in the promoter region of target genes
      • Recruitment of Coactivators:
        • Coactivators are proteins that enhance gene transcription
        • They include histone acetyltransferases (HATs), which modify chromatin structure to make DNA more accessible
      • Recruitment of Corepressors:
        • Corepressors are proteins that inhibit gene transcription
        • They include histone deacetylases (HDACs), which modify chromatin structure to make DNA less accessible
    • Termination of Signal:
      • Hormone dissociates from the receptor, inactivating the complex
      • Protein phosphatases remove phosphate groups from transcription factors

Examples of Hormones and Their Mechanisms of Action

  • Insulin: Binds to receptor tyrosine kinase, activating the PI3K/Akt pathway and promoting glucose uptake
  • Glucagon: Binds to G protein-coupled receptor, activating adenylyl cyclase and increasing cAMP levels
  • Epinephrine: Binds to adrenergic receptors (GPCRs), activating adenylyl cyclase or phospholipase C
  • Cortisol: Binds to intracellular glucocorticoid receptor, regulating gene transcription
  • Thyroid Hormone: Binds to intracellular thyroid hormone receptor, regulating gene transcription

Clinical Significance

  • Drug Development: Understanding hormone receptor signaling pathways is crucial for developing drugs that target specific hormone-related disorders
    • Agonists: Drugs that activate hormone receptors
    • Antagonists: Drugs that block hormone receptors
  • Hormone Resistance: Mutations in hormone receptors can lead to hormone resistance, where target tissues fail to respond normally to hormones
  • Cancer: Aberrant hormone signaling can contribute to cancer development and progression
  • Autoimmune Disorders: In some autoimmune disorders, antibodies target hormone receptors, leading to either overstimulation or blockade of hormone signaling

Key Terms

  • Hormone Receptor: A protein that binds to a specific hormone
  • Cell Surface Receptor: A receptor located on the cell membrane
  • Intracellular Receptor: A receptor located within the cell
  • G Protein-Coupled Receptor (GPCR): A receptor that activates intracellular signaling pathways through G proteins
  • Receptor Tyrosine Kinase (RTK): A receptor that initiates phosphorylation cascades
  • Second Messenger: An intracellular signaling molecule, such as cAMP, IP3, or DAG
  • Protein Kinase: An enzyme that phosphorylates proteins
  • Transcription Factor: A protein that regulates gene transcription
  • DNA Response Element (HRE): A specific DNA sequence that binds to hormone-receptor complexes
  • Agonist: A drug that activates a hormone receptor
  • Antagonist: A drug that blocks a hormone receptor
  • Hormone Resistance: A condition where target tissues fail to respond normally to a hormone due to receptor defects or post-receptor signaling abnormalities
  • Autophosphorylation: The phosphorylation of a protein by itself
  • Dimerization: The formation of a complex between two identical proteins